Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

195 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessment of Postvaccination Neutralizing Antibodies Response against SARS-CoV-2 in Cancer Patients under Treatment with Targeted Agents.
Zagouri F, Papatheodoridi A, Liontos M, Briasoulis A, Sklirou AD, Skafida E, Fiste O, Markellos C, Andrikopoulou A, Koutsoukos K, Kaparelou M, Gkogkou E, Trougakos IP, Dimopoulos MA, Terpos E. Zagouri F, et al. Among authors: trougakos ip. Vaccines (Basel). 2022 Sep 5;10(9):1474. doi: 10.3390/vaccines10091474. Vaccines (Basel). 2022. PMID: 36146552 Free PMC article.
Cancer chemoprevention via activation of proteostatic modules.
Sklirou A, Papanagnou ED, Fokialakis N, Trougakos IP. Sklirou A, et al. Among authors: trougakos ip. Cancer Lett. 2018 Jan 28;413:110-121. doi: 10.1016/j.canlet.2017.10.034. Epub 2017 Oct 26. Cancer Lett. 2018. PMID: 29107114 Review.
Evaluation of minimal residual disease using next-generation flow cytometry in patients with AL amyloidosis.
Kastritis E, Kostopoulos IV, Terpos E, Paiva B, Fotiou D, Gavriatopoulou M, Kanellias N, Ziogas DC, Roussou M, Migkou M, Eleutherakis-Papaiakovou E, Trougakos IP, Tsitsilonis O, Dimopoulos MA. Kastritis E, et al. Among authors: trougakos ip. Blood Cancer J. 2018 May 24;8(5):46. doi: 10.1038/s41408-018-0086-3. Blood Cancer J. 2018. PMID: 29795385 Free PMC article. No abstract available.
Consolidation therapy with the combination of bortezomib and lenalidomide (VR) without dexamethasone in multiple myeloma patients after transplant: Effects on survival and bone outcomes in the absence of bisphosphonates.
Terpos E, Kastritis E, Ntanasis-Stathopoulos I, Christoulas D, Papatheodorou A, Eleutherakis-Papaiakovou E, Kanellias N, Fotiou D, Ziogas DC, Migkou M, Roussou M, Trougakos IP, Gavriatopoulou M, Dimopoulos MA. Terpos E, et al. Among authors: trougakos ip. Am J Hematol. 2019 Apr;94(4):400-407. doi: 10.1002/ajh.25392. Epub 2019 Jan 10. Am J Hematol. 2019. PMID: 30592079 Free article. Clinical Trial.
195 results